Drug
Ibandronic Acid
Ibandronic Acid: highest development phase Phase 3, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| ibandronic acid 0.5mg NCT00447915 | Phase 3 | Primary Osteoporosis |
Latest
No recent events.
Follow Ibandronic Acid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.